---
title: "12 Health Care Stocks Moving In Monday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291175379.md"
description: "During Monday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Universe Pharmaceuticals (UPC), which surged 284.8% to $11.39, and Decoy Therapeutics (DCOY), up 91.19%. Other notable gainers were QuidelOrtho, Atlantic International, Pulsenmore, and Tvardi Therapeutics. On the losing side, Bluejay Diagnostics (BJDX) plummeted 55.3%, followed by Evommune, Creative Medical Tech, Jupiter Neurosciences, Shuttle Pharmaceuticals, and China SXT Pharmaceuticals."
datetime: "2026-06-29T17:05:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291175379.md)
  - [en](https://longbridge.com/en/news/291175379.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291175379.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's Intraday Session

### Gainers

-   **Universe Pharmaceuticals** (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday's regular session. The company's market cap stands at $1.9 million.
-   **Decoy Therapeutics** (NASDAQ:DCOY) shares moved upwards by 91.19% to $10.55. The market value of their outstanding shares is at $2.9 million.
-   **QuidelOrtho** (NASDAQ:QDEL) shares rose 33.86% to $18.46. The market value of their outstanding shares is at $939.0 million.
-   **Atlantic International** (NASDAQ:ATLN) shares increased by 30.64% to $1.11. The company's market cap stands at $69.0 million.
-   **Pulsenmore** (NASDAQ:PLSM) stock increased by 27.69% to $7.1. The market value of their outstanding shares is at $36.1 million.
-   **Tvardi Therapeutics** (NASDAQ:TVRD) shares increased by 27.0% to $1.91. The company's market cap stands at $14.0 million.

### Losers

-   **Bluejay Diagnostics** (NASDAQ:BJDX) stock declined by 55.3% to $1.31 during Monday's regular session. The company's market cap stands at $3.0 million.
-   **Evommune** (NYSE:EVMN) shares decreased by 37.4% to $15.77. The market value of their outstanding shares is at $906.9 million.
-   **Creative Medical Tech** (NASDAQ:CELZ) shares declined by 27.5% to $0.87. The market value of their outstanding shares is at $4.4 million.
-   **Jupiter Neurosciences** (NASDAQ:JUNS) stock fell 26.29% to $0.21. The market value of their outstanding shares is at $13.5 million.
-   **Shuttle Pharmaceuticals** (NASDAQ:SHPH) stock fell 19.16% to $3.25. The company's market cap stands at $2.3 million.
-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) shares declined by 17.36% to $2.0. The company's market cap stands at $10.7 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [PLSM.US](https://longbridge.com/en/quote/PLSM.US.md)
- [JUNS.US](https://longbridge.com/en/quote/JUNS.US.md)
- [SHPH.US](https://longbridge.com/en/quote/SHPH.US.md)
- [DCOY.US](https://longbridge.com/en/quote/DCOY.US.md)
- [UPC.US](https://longbridge.com/en/quote/UPC.US.md)
- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)
- [TVRD.US](https://longbridge.com/en/quote/TVRD.US.md)
- [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [QDEL.US](https://longbridge.com/en/quote/QDEL.US.md)
- [ATLN.US](https://longbridge.com/en/quote/ATLN.US.md)
- [EVMN.US](https://longbridge.com/en/quote/EVMN.US.md)
- [SQLLW.US](https://longbridge.com/en/quote/SQLLW.US.md)

## Related News & Research

- [Israel Innovation Authority approves USD 1.27 million AI grant for Pulsenmore SmartScan program](https://longbridge.com/en/news/296094873.md)
- [Tvardi Therapeutics: TTI-109 advanced for UC after positive topline results; Q2 net loss was $6.5 million](https://longbridge.com/en/news/295925308.md)
- [Tvardi Therapeutics (TVRD) Gets a Sell from Barclays](https://longbridge.com/en/news/295203580.md)
- [Bluejay Diagnostics says SYMON-II pivotal study completes enrollment of 750 patients for Symphony IL-6 test](https://longbridge.com/en/news/295778817.md)
- [Shuttle Pharmaceuticals amends 8-K, says UDC merger not significant and financials not required](https://longbridge.com/en/news/296146163.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**